Polypeptide Arrays for Early Breast Cancer Autoantibody Detection
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current breast cancer detection methods face challenges in identifying small quantities of protein fragments within complex protein mixtures, protein instability, and natural variations in protein content, leading to poor sensitivity of tumor-specific autoantibodies, which are not widely used due to labor and technical issues in protein microarray production and validation.
Innovation Solution
Development of polypeptide and polynucleotide arrays comprising specific polypeptides and nucleic acids, such as ATP6AP1, PDCD6IP, and others, attached to a support, for detecting tumor antigen-specific autoantibodies in bodily fluids, using techniques like NAPPA and immobilization on various substrates.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Productivity
If protein microarrays are used to detect tumor antigens, then the ability to screen multiple antigens simultaneously is improved, but the labor and technical complexity of production and quality control worsens
Solution Approach 1:
The patent uses cDNA as a template to create polypeptide copies via in vitro transcription and translation systems. This allows multiple identical copies of each polypeptide to be generated from a single cDNA template, eliminating the need for manual protein purification and spotting while maintaining array integrity and reproducibility
Solution Approach 2:
The patent introduces an intermediary in vitro transcription-translation system that converts cDNA templates into functional polypeptides. This intermediary system bridges the gap between simple cDNA printing and complex protein production, allowing arrays to be assembled from nucleic acid templates rather than purified proteins, thereby simplifying production while maintaining detection capability
2Reliability
If traditional protein purification methods are used, then protein quality is maintained, but the time and labor required for production increases
Solution Approach 1:
The in vitro transcription-translation system is self-service in that it automatically synthesizes polypeptides from cDNA templates without requiring external purification steps. The system performs transcription and translation in a single reaction mixture, and the polypeptides are directly ready for array assembly, eliminating time-consuming purification protocols while maintaining protein quality
Solution Approach 2:
The patent performs preliminary synthesis of polypeptides in the in vitro system before array assembly. By pre-synthesizing all required polypeptides in controlled reactions with known concentrations and purities, the method eliminates the need for time-consuming quality control and purification steps during array production, as the preliminary synthesis step already ensures protein quality
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The arrays provide accurate and sensitive detection of breast cancer, with a likelihood of diagnosis in at least 70% of cases, offering valuable diagnostic and prognostic information through the presence of autoantibodies to these polypeptides.
Implementation Method 1
contacting a bodily fluid sample obtained from a subject with one or more isolated polypeptides... under conditions suitable for selective binding of antibodies in the bodily fluid sample to the one or more polypeptides
Data Source
AI summary
The present invention provides reagents and methods for breast cancer detection.